Journal of medicinal chemistry

Khellin analogs. 1. General topological requirements for lipid-altering activity in furochromones

RB Gammill, CE Day, PE Schurr

文献索引：Gammill, Ronald B.; Day, Charles E.; Schurr, Paul E. Journal of Medicinal Chemistry, 1983 , vol. 26, # 12 p. 1672 - 1674

全文：HTML全文

被引用次数: 41

摘要

1, 16.(7)(a) For an excellent discussion of this subject and additional references, see: Wolinsky, H. Circ. Res. 1980, 47, 301.(b) Fredrickson, DS; Brown, MS; Goldstein, JL “The Metabolic Basis of Inherited Disease”, 4th ed.; Stanburg, JB; Wyngaarden, JB; Fredrickson, DS; McGraw-Hill, New York, 1978; p 604.(c) Tall, AR; Small, DM; Atkinson, D.; Rudel, LL J. Clin. Invest. 1978, 42, 1354. erogenic. HDL cholesterol has been demonstrated to be a ...